Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM
POXSPERM
2 other identifiers
interventional
30
1 country
1
Brief Summary
Given the current emerging epidemic of the MonkeyPox Virus (MPXV) and its route of transmission, the main objective of this pilot study is to characterize the presence of the MPXV in the semen of patients in the acute phase of infection and following this infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedNovember 29, 2022
November 1, 2022
2 years
November 15, 2022
November 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MPXV genomic DNA
presence of MPXV DNA in the semen and others body fluids of infected patients in the acute phase and during the follow-up.
Day 0
Study Arms (1)
Monkey Pox infection
OTHERMen will give semen, saliva, skin, urine and blood specimens
Interventions
Eligibility Criteria
You may qualify if:
- in the acute phase of MPXV infection and whose PCR reveals the viral genome in a skin sample or in any other sample.
- able to travel to the laboratory for the samples
- who gave his free and informed consent and having signed the consent
- Patient affiliated to a social security scheme or equivalent
You may not qualify if:
- Patient who has previously consulted for male infertility or who has previously performed an abnormal semen test (WHO standard)
- Patient with ejaculation disorder or unable to collect semen or with abnormal semen volume (\<1.5 mL).
- Patient who presents serious clinical signs that do not allow him to travel to the investigation center.
- Patient under a protection regime (including guardianship, curatorship or safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Toulouse
Toulouse, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manon CARLES, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2022
First Posted
November 29, 2022
Study Start
November 1, 2022
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
November 29, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share